Table 4.
Individuals <65 years | Individuals ≥65 years | |||||||
---|---|---|---|---|---|---|---|---|
CHIP HR (95% CI) | p‐value | DNMT3A HR (95% CI) | p‐value | CHIP HR (95% CI) | p‐value | DNMT3A HR (95% CI) | p‐value | |
Incident HF | 2.07 (1.30–3.29) | 0.002 | 2.13 (1.25–3.61) | 0.005 | 0.95 (0.66–1.36) | 0.773 | 1.29 (0.86–1.95) | 0.220 |
Incident HFrEF | 1.45 (0.79–2.66) | 0.233 | 1.35 (0.66–2.76) | 0.416 | 1.01 (0.65–1.58) | 0.957 | 1.23 (0.74–2.06) | 0.425 |
Incident HFpEF | 2.11 (1.01–4.41) | 0.048 | 2.26 (1.01–5.04) | 0.047 | 0.78 (0.41–1.49) | 0.447 | 1.10 (0.54–2.23) | 0.789 |
CHIP, clonal haematopoiesis of indeterminate potential; CI, confidence interval; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; HR, hazard ratio.
Cox regression models were adjusted for age, sex, smoking, diabetes, hypertension, body mass index, cholesterol, history of myocardial infarction, atrial fibrillation and cerebrovascular accident.